Table 1.
Characteristics of included patients (n = 528).
| Characteristic | n (%) |
|---|---|
| Median age (IQR 1), years | 74 (52–84) |
| Male sex | 291 (55.1) |
| Diabetes | 123 (23.3) |
| Cardiovascular disease 2 | 171 (32.4) |
| Active cancer | 32 (6.1) |
| Estimated GFR (mL/min/1.73 m2): | |
| Above 89 (CKD 3 stage 0 and 1) | 241 (45.6) |
| 60 to 89 (CKD stage 2) | 181 (34.3) |
| 30 to 59 (CKD stage 3) | 94 (17.8) |
| Below 30 (CKD stage 4 and 5) | 12 (2.3) |
| Acute kidney injury: | |
| None | 252 (47.7) |
| Stage 1 | 124 (23.5) |
| Stage 2 | 63 (11.9) |
| Stage 3 | 89 (16.9) |
| Sepsis | 84 (15.9) |
| Illicit drug use | 69 (13.1) |
| Chronic liver disease | 62 (11.7) |
| History of excessive alcohol intake | 100 (18.9) |
| Use of potentially hepatotoxic medications | 311 (58.9) |
| Statin treatment 4 | 188 (35.6) |
1 Interquartile range; 2 Composite of coronary artery disease, peripheral vascular disease, and stroke; 3 Chronic kidney disease; 4 Subgroup of potentially hepatotoxic medications.